WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006085112) ANTHRANILIC ACID DERIVATIVES AS HM74A RECEPTOR AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/085112    International Application No.:    PCT/GB2006/000508
Publication Date: 17.08.2006 International Filing Date: 14.02.2006
IPC:
C07D 253/08 (2006.01), C07D 401/04 (2006.01), C07D 271/06 (2006.01), C07C 235/24 (2006.01), A61K 31/53 (2006.01), A61K 31/4245 (2006.01), A61K 31/196 (2006.01), A61P 9/10 (2006.01)
Applicants: SMITHKLINE BEECHAM CORPORATION [US/US]; One Franklin Plaza, PO Box 7929, Philadelphia, Pennsylvania 19101 (US) (For All Designated States Except US).
HATLEY, Richard [GB/GB]; (GB) (For US Only).
MASON, Andrew, Mcmurtrie [GB/GB]; (GB) (For US Only).
PINTO, Ivan, Leo [GB/GB]; (GB) (For US Only).
SMITH, Ian, Edward, David [GB/GB]; (GB) (For US Only)
Inventors: HATLEY, Richard; (GB).
MASON, Andrew, Mcmurtrie; (GB).
PINTO, Ivan, Leo; (GB).
SMITH, Ian, Edward, David; (GB)
Agent: THORNLEY, Rachel, Mary; GlaxoSmithKline, Corporate Intellectual Property, 980 Great West Road, Brentford Middlesex TW8 9GS (GB)
Priority Data:
0503035.8 14.02.2005 GB
0503567.0 21.02.2005 GB
Title (EN) ANTHRANILIC ACID DERIVATIVES AS HM74A RECEPTOR AGONISTS
(FR) DERIVES DE L'ACIDE ANTHRANILIQUE COMME AGONISTES DU RECEPTEUR HM74A
Abstract: front page image
(EN)Therapeutically active anthranilic acid derivatives of Formula (I) wherein R1, R2 and W, are as defined in the specification, processes for the preparation of said derivatives, pharmaceutical formulations containing the active compounds and the use of the compounds in therapy, particularly in the treatment of diseases in which under-activation of the HM74A receptor contributes to the disease or in which activation of the receptor will be beneficial, are disclosed.
(FR)La présente invention concerne des dérivés de l'acide anthranilique thérapeutiquement actifs, de formule (I), où R1, R2 et W sont tels que définis dans la description, des procédés de préparation desdits dérivés, des formulations pharmaceutiques contenant les composés actifs et l'utilisation des composés en thérapie, particulièrement dans le traitement de maladies dans lesquelles une sous-activation du récepteur HM74A contribue à la maladie ou dans lesquelles l'activation du récepteur sera bénéfique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)